Log In
Print this Print this

SPD 535

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionAnagrelide analog
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationArterial thrombosis
Indication DetailsPrevent thrombotic complications associated with arteriovenous grafts in hemodialysis patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today